ARCHIVES

Urgent FDA Action Turns Power Morcellation Into Rarely Used Gynecological Procedure

This article is from The Cancer Letter archive.

Vol. 40 No. Nov 26 special report | November 26, 2014

Download PDF Visit The Full Archive

Related Articles

Letter to the Editor: Gensia Official Says No “Threat” Implied In Question Study

May 26, 1995

FDA Approves Femara As First-Line Treatment For Advanced Breast Cancer.

January 26, 2001

Organizations Ask Senate To Increase NCI Appropriations, Order OMB To “Get Nose Out Of Tent”

May 2, 1986

Komen, ACS Support Payment Off-Protocol; Dilemma for Advocates

April 16, 1999

NCI Offers Model Informed Consent Documents

November 6, 1998

Program Announcements, RFA In Radiation Effects Available

September 24, 1982